The study highlights a presymptomatic phase in type 1 diabetes progression, using immune niches to track immune changes ...
A patient with complete blindness caused by irreversible optic nerve damage partially recovered natural vision after ...
Among patients with MCL still on study in January 2025, 35.3% reported improved MCL-related symptoms, while 5.9% reported ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...
There are news stories that do not arrive wrapped in epic narratives, nor in strident promises, nor in headlines designed to excite hope. They arrive in ...
The API Management Services Market is driven by rapid digital transformation across enterprises, increasing adoption of ...
Emerging research has provided fresh evidence regarding the role of viral infection in the development of multiple sclerosis.
Dr. David Nathanson is a professor of molecular and medical pharmacology at UCLA. He received his Ph.D. in molecular and medical pharmacology at UCLA under Dr. Paul Mischel, where he discovered that ...
In his weekly column for ILM, Mike Redwood reflects on leather's story of durability, including the societal shift from ...
BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...